Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05989841 · ClinicalTrials.gov registry record · Phase 1

Mitigating PTSD-CUD After Sexual Assault

A Phase 1 study of Posttraumatic Stress Disorder and Cannabis Use Disorder, sponsored by University of Nevada, Las Vegas.

Recruiting
Registry status
Phase 1
Development phase
68
Enrollment target
6
Study locations

NCT05989841 is a Phase 1 study of Posttraumatic Stress Disorder and Cannabis Use Disorder that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 68 participants, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (39% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05989841, a Phase 1 study of Posttraumatic Stress Disorder and Cannabis Use Disorder, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.

RECRUITING
Registry status
Phase 1
Development phase
68 participants
Enrollment target
6
Study locations

Study Summary

683,000 women are sexually assaulted annually in the United States, half of whom develop chronic posttraumatic stress disorder (PTSD) and thus have markedly increased risk for cannabis use disorder (CUD). The current proposal will test the acceptability, initial efficacy, and mechanisms underlying a novel digital therapeutic targeting risk for PTSD-CUD, which could address the critical need for PTSD-CUD prevention for the 100,000 women who annually present for emergency care after sexual assault. In this research context, the applicant will receive key training in multisite, emergency-care based randomized clinical trials (RCTs), advanced statistical analyses for RCTs and ecological momentary assessment data, biobehavioral mechanisms underlying PTSD-CUD prevention, and professional development, launching her independent research career focused on reducing the public health burden of PTSD-CUD among sexual assault survivors by leveraging digital therapeutics.

Interventions

  • BEHAVIORAL RISE Guide
  • BEHAVIORAL Relaxation Control

Study Locations (6)

North Carolina

  • UNC Chapel Hill - Chapel Hill
  • Harbor Shelter - Smithfield

Minnesota

  • Hennepin Assault Response Team - Minneapolis

Nevada

  • University Medical Center - Las Vegas

Oklahoma

  • Tulsa Forensic Nursing - Tulsa

Texas

  • SAFE Austin - Austin

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2024-03-14
Est. Completion 2028-02-29
Phase Phase 1

Sponsor

University of Nevada, Las Vegas

52 total trials

What the Registry Record Tells You About NCT05989841

The ClinicalTrials.gov registry entry for NCT05989841 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (39% lower). The listed sponsor is University of Nevada, Las Vegas, which has 52 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which RISE Guide is the first listed.

NCT05989841 reports 6 study locations spanning 5 distinct geographic areas - top geographies include North Carolina, Minnesota, Nevada.

Frequently Asked Questions

What is clinical trial NCT05989841 about?

NCT05989841 is a clinical study titled "Mitigating PTSD-CUD After Sexual Assault". 683,000 women are sexually assaulted annually in the United States, half of whom develop chronic posttraumatic stress disorder (PTSD) and thus have markedly increased risk for cannabis use disorder (CUD). The current proposal will test the acceptability, initial efficacy, and mechanisms underlying a...

What is the current status of trial NCT05989841?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2024-03-14. Estimated completion is 2028-02-29.

What conditions does trial NCT05989841 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Cannabis Use Disorder.

What interventions are being tested in trial NCT05989841?

The interventions under investigation include: RISE Guide (BEHAVIORAL), Relaxation Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT05989841?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05989841 being conducted?

This trial has 6 study locations across Minnesota, Nevada, North Carolina, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.